PRP Concepts, Inc. — SEC Form D Filing
PRP Concepts, Inc. filed an SEC Form D on August 6, 2026, reporting $1.50M raised in Medical Devices.
Form D filing details
- Filing
- SEC Form D
- Filing date
- August 6, 2026
- Amount reported
- $1.50M
- Industry
- Medical Devices
- Website
- https://prpconcepts.com/
What the company does
Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Chronic wounds disrupt the natural healing cycle, leading to delayed recovery and increased complications for patients. Current standard treatments often fall short in addressing these complex wounds, which affect a significant portion of the population.
Solution
PRP Concepts™ developed the CASCADE® Autologous Platelet System, an FDA 510(k)-cleared medical device that creates a Platelet-Rich Fibrin Membrane (PRFM) from a patient's own blood. This membrane provides sustained growth factor release directly to the wound, optimizing the body's ability to heal and accelerating wound closure.
Why now
There is an urgent need for more effective and cost-efficient treatments for chronic wounds, particularly diabetic foot ulcers, due to the increasing prevalence of diabetes and the high economic and health burden of these conditions.
Verdict
This cleared because it presented a tangible product in an established market with a clear, unmet medical need, not because it promised a novel technological breakthrough. Investors were implicitly betting on the company's ability to navigate regulatory hurdles and capture market share from existing, less effective treatments. The limited upside stemmed from the highly competitive and reimbursement-dependent nature of the medical device space, where long sales cycles and entrenched solutions create significant adoption barriers.
Source: SEC EDGAR Form D filing